Specifically, the spleen tyrosine kinase (SYK, in cluster E), expressed in majority of hematopoietic cells, has been recognized as a therapeutic target in autoimmune diseases such as rheumatoid arthritis (Geahlen, 2014). The gene discussed is SYK; the disease is autoimmune disease.